The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
- PMID: 30565667
- DOI: 10.1002/jcp.27445
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
Abstract
MicroRNAs (miRNAs) regulate several biological and physiological processes in mammalian cells, including cellular proliferation, differentiation, apoptosis, and metabolism. Recent studies have confirmed the alteration of them during the cancer development. Matrix metalloproteinases (MMPs), belonging to the large family of proteases, have also been demonstrated to play crucial roles in tissue remodeling, and to support cancer progression and metastasis. There are several known miRNAs which regulate the MMP family and their expression. The expression profiles of miRNAs involved in MMP regulation, change during cancer progression, and metastasis. The present review focuses on important miRNAs capable of targeting MMPs through direct and indirect interactions during the breast cancer development, progression, and metastasis.
Keywords: breast cancer; matrix metalloproteinases; metastasis; microRNA; progression.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.Anticancer Res. 2014 Mar;34(3):1355-66. Anticancer Res. 2014. PMID: 24596383
-
Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.Tumour Biol. 2016 Aug;37(8):10011-9. doi: 10.1007/s13277-016-5060-8. Epub 2016 May 6. Tumour Biol. 2016. PMID: 27153853 Review.
-
New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.J Cell Physiol. 2011 Dec;226(12):3378-84. doi: 10.1002/jcp.22694. J Cell Physiol. 2011. PMID: 21344390
-
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.J Cell Physiol. 2008 Dec;217(3):739-44. doi: 10.1002/jcp.21548. J Cell Physiol. 2008. PMID: 18651563
-
miRNAs in breast cancer tumorigenesis (Review).Oncol Rep. 2012 Apr;27(4):903-10. doi: 10.3892/or.2011.1611. Epub 2011 Dec 23. Oncol Rep. 2012. PMID: 22200848 Free PMC article. Review.
Cited by
-
Intricate crosstalk between MYB and noncoding RNAs in cancer.Cancer Cell Int. 2021 Dec 7;21(1):653. doi: 10.1186/s12935-021-02362-4. Cancer Cell Int. 2021. PMID: 34876130 Free PMC article. Review.
-
Estrogenic control of matrix metalloproteinases: a perspective on breast tumor invasion and metastasis.Mol Biol Rep. 2025 May 13;52(1):453. doi: 10.1007/s11033-025-10555-7. Mol Biol Rep. 2025. PMID: 40358843 Review.
-
Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells.J Cancer. 2019 Oct 18;10(25):6341-6348. doi: 10.7150/jca.34910. eCollection 2019. J Cancer. 2019. PMID: 31772666 Free PMC article.
-
An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.Oncol Lett. 2019 Sep;18(3):2985-2994. doi: 10.3892/ol.2019.10669. Epub 2019 Jul 26. Oncol Lett. 2019. PMID: 31452777 Free PMC article.
-
Anemoside A3 Inhibits Macrophage M2-Like Polarization to Prevent Triple-Negative Breast Cancer Metastasis.Molecules. 2023 Feb 7;28(4):1611. doi: 10.3390/molecules28041611. Molecules. 2023. PMID: 36838599 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical